Clinical Trial: A Randomized, Phase 3 Multicenter Clinical Trial to Confirm the Clinical Efficacy and Evaluate the Safety of Linaprazan Glurate Compared to Lansoprazole in Participants With Healed Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)

U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07313774) titled 'A Randomized, Phase 3 Multicenter Clinical Trial to Confirm the Clinical Efficacy and Evaluate the Safety of Linaprazan Glurate Compared to Lansoprazole in Participants With Healed Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD)' on Dec. 19, 2025.

Brief Summary: The goal of this clinical trial is to investigate how well linaprazan glurate can maintain healed erosive esophagitis (EE) caused by GERD in participants who have participated in a prior healing trial, compared to lansoprazole (an approved treatment for GERD). Researchers will also examine:

* the effect of linaprazan glurate on heartburn symptoms compa...